20-56631317-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003222.4(TFAP2C):c.161A>T(p.Tyr54Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,457,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003222.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFAP2C | NM_003222.4 | c.161A>T | p.Tyr54Phe | missense_variant | 2/7 | ENST00000201031.3 | NP_003213.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFAP2C | ENST00000201031.3 | c.161A>T | p.Tyr54Phe | missense_variant | 2/7 | 1 | NM_003222.4 | ENSP00000201031 | P1 | |
TFAP2C | ENST00000416606.1 | c.125A>T | p.Tyr42Phe | missense_variant | 2/2 | 3 | ENSP00000390857 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000815 AC: 2AN: 245428Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133094
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457394Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 724916
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.161A>T (p.Y54F) alteration is located in exon 2 (coding exon 2) of the TFAP2C gene. This alteration results from a A to T substitution at nucleotide position 161, causing the tyrosine (Y) at amino acid position 54 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at